HTML Full Text

Reference

1. Ammouch K, Mesmoudi N, Hammani N, Galan J, Moustaghfir A, Stöcklin R, et al. Tackling the burden of envenomation in Africa: Advances, challenges, and strategic priorities for enhanced diagnosis and treatment. Front Trop Dis. 2025;6:1. https://doi.org/10.3389/FITD.2025.1653213/FULL

2. World Health Organization. Guidelines for the Management of Snakebite. 2^nd ed. Geneva: World Health Organization; 2016. p. 140.

3. Snakebite Envenoming. Available from: https://www.who.int/news-room/fact-sheets/detail/snakebite-envenoming [Last accessed on 2025 Nov 11].

4. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, et al. The global burden of snakebite: A literature analysis and modelling based on regional estimates of envenoming and deaths. Winkel K, editor. PLoS Medicine. 2008;5(11):e218. https://dx.plos.org/10.1371/journal.pmed.0050218

5. Control of Neglected Tropical Diseases [Internet]. [cited 2025 November 11]. Available from: https://www.who.int/teams/control-of-neglected-tropical-diseases/snakebite-envenoming/prevention-and-control

6. Oliveira IS, Pucca MB, Cerni FA, Vieira S, Sachett J, de Farias AS, et al. Snakebite envenoming in Brazilian children: clinical aspects, management and outcomes. J Trop Pediatr. 2023;69(2):fmad010. doi: https://doi.org/10.1093/tropej/fmad010.

7. Munshi H, Gajbhiye RK. Strengthening global snakebite data for WHO’s goal for 2030. Lancet. 2024;403:907-8. https://doi.org/10.1016/S0140-6736(23)01698-7

8. Pintor AF, Ray N, Longbottom J, Bravo-Vega CA, Yousefi M, Murray KA, et al. Addressing the global snakebite crisis with geo-spatial analyses - recent advances and future direction. Toxicon X. 2021;11:100076. https://doi.org/10.1016/j.toxcx.2021.100076

9. Casewell NR, Jackson TN, Laustsen AH, Sunagar K. Causes and consequences of snake venom variation. Trends Pharmacol Sci. 2020;41:570-81. https://doi.org/10.1016/j.tips.2020.05.006

10. Gutiérrez J, Escalante T, Rucavado A, Herrera C, Fox JW. A comprehensive view of the structural and functional alterations of extracellular matrix by snake venom metalloproteinases (SVMPs): Novel perspectives on the pathophysiology of envenoming. Toxins (Basel). 2016;8:304. https://doi.org/10.3390/toxins8100304

11. Bittenbinder MA, Van Thiel J, Cardoso FC, Casewell NR, Gutiérrez JM, Kool J, et al. Tissue damaging toxins in snake venoms: Mechanisms of action, pathophysiology and treatment strategies. Commun Biol. 2024;7:358. https://doi.org/10.1038/s42003-024-06019-6

12. Blanch NB, Cascone O, Fingermann M. Selective immunoglobulin aggregates removal in antivenoms by a simple chromatographic step based on a monolithic stationary phase. J Chromatogr B Analyt Technol Biomed Life Sci. 2024;1232:123978. https://doi.org/10.1016/j.jchromb.2023.123978

13. Potet J, Beran D, Ray N, Alcoba G, Habib AG, Iliyasu G, et al. Access to antivenoms in the developing world: A multidisciplinary analysis. Toxicon X. 2021;12:100086. https://doi.org/10.1016/j.toxcx.2021.100086

14. O’Brien J, Lee SH, Gutiérrez JM, Shea KJ.Engineered nanoparticles bind elapid snake venom toxins and inhibit venom-induced dermonecrosis. PLoS Negl Trop Dis. 2018;12:e0006736. https://doi.org/10.1371/journal.pntd.0006736

15. World Health Organization. WHO Expert Committee on Biological Standardization. Guidelines for the production, control and regulation of snake antivenom immunoglobulins [Internet]. 2012 [cited 2025 November 11]; (964):591. Available from: https://cdn.who.int/media/docs/default-source/biologicals/blood-products/document-migration/resriskgl_who_trs_1004_web_annex_4.pdf?sfvrsn=55dd09d3_3&download=true

16. Puzari U, Fernandes PA, Mukherjee AK. Pharmacological re-assessment of traditional medicinal plants-derived inhibitors as antidotes against snakebite envenoming: A critical review. J Ethnopharmacol. 2022;292:115208. https://doi.org/10.1016/j.jep.2022.115208

17. Laustsen AH, María Gutiérrez J, Knudsen C, Johansen KH, Bermúdez-Méndez E, Cerni FA, et al. Pros and cons of different therapeutic antibody formats for recombinant antivenom development. Toxicon. 2018;146:151-75. https://doi.org/10.1016/j.toxicon.2018.03.004

18. Mohapatra B, Warrell DA, Suraweera W, Bhatia P, Dhingra N, Jotkar RM, et al. The timing is right to end snakebite deaths in South Asia. BMJ.2019;364:k5317. doi:10.1136/bmj.k5317.

19. Tibballs J, Kuruppu S, Hodgson WC, Carroll T, Hawdon G, Sourial M, et al. Cardiovascular, haematological and neurological effects of the venom of the Papua New Guinean small-eyed snake (Micropechis ikaheka) and their neutralisation with CSL polyvalent and black snake antivenoms. Toxicon. 2003;42:647-55. https://doi.org/10.1016/j.toxicon.2003.09.002

20. Boels D, Hamel JF, Le Roux G, Labadie M, Paret N, Delcourt N, et al. Snake bites by European vipers in Mainland France in 2017-2018: Comparison of two antivenoms Viperfav® and Viperatab®. Clin Toxicol (Phila). 2020;58:1050-7. https://doi.org/10.1080/15563650.2020.1726377

21. Jimenez-Canale J, Fernández-Quiroz D, Teran-Saavedra NG, Diaz-Galvez KR, Gallegos-Tabanico A, Burgara-Estrella AJ, et al. Cytotoxic activity of Crotalus molossus molossus snake venom-loaded in chitosan nanoparticles against T-47D breast carcinoma cells. Acta Biochim Pol. 2022;69:233-43. https://doi.org/10.18388/abp.2020_5975

22. Maduwage K, Silva A, O’Leary MA, Hodgson WC, Isbister GK. Efficacy of Indian polyvalent snake antivenoms against Sri Lankan snake venoms: Lethality studies or clinically focussed in vitro studies. Sci Rep. 2016;6:26778. https://doi.org/10.1038/srep26778

23. Deka A, Bhatia S, Santra V, Bharti OK, Lalremsanga HT, Martin G, et al. Multilevel comparison of Indian Naja venoms and their cross-reactivity with Indian polyvalent antivenoms. Toxins (Basel). 2023;15:258. https://doi.org/10.3390/toxins15040258

24. Valente RH, Dragulev B, Perales J, Fox JW, Domont GB. BJ46a, a snake venom metalloproteinase inhibitor. Isolation, characterization, cloning and insights into its mechanism of action. Eur J Biochem. 2001;268:3042-52. https://doi.org/10.1046/j.1432-1327.2001.02199.x

25. Gutiérrez JM, Vargas M, Segura Á, Herrera M, Villalta M, Solano G, et al. In vitro tests for assessing the neutralizing ability of snake antivenoms: Toward the 3Rs principles. Front Immunol. 2021;11:1-13. https://doi.org/10.3389/fimmu.2020.617429

26. Sánchez M, Solano G, Vargas M, Reta-Mares F, Neri-Castro É, Alagón A, et al. Toxicological profile of medically relevant Crotalus species from Mexico and their neutralization by a Crotalus basiliscus/Bothrops asper antivenom. Toxicon. 2020;179:92-100. https://doi.org/10.1016/j.toxicon.2020.03.006

27. Acconci C, Legallais C, Vijayalakshmi M, Bueno SM. Depyrogenation of snake antivenom serum solutions by hollow fiber-based pseudobioaffinity filtration. J Memb Sci. 2000;173:235-45. https://doi.org/10.1016/S0376-7388(00)00377-X

28. De Freitas SS, MacHado RL, De Arruda EJ, Santana CC, Bueno SM. Endotoxin removal from solutions of F(ab′)2 fragments of equine antibodies against snake venom using macroporous chitosan membrane. J Memb Sci. 2004;234:67-73. https://doi.org/10.1016/j.memsci.2003.12.019

29. Sheraba NS, Diab MR, Yassin AS, Amin MA, Alhamhoom Y. An efficient method for endotoxin removal from snake antivenoms. Chromatographia. 2020;83:779-87. https://doi.org/10.1007/s10337-020-03887-y

30. Sheraba NS, Hesham A, Fawzy M, Diab E, Basuony ME, Yassin AS, et al. Advanced approaches for endotoxin detection and removal from snake antivenoms. Toxicon. 2023;222:107003. https://doi.org/10.1016/j.toxicon.2022.107003

31. Wespel M, Geiss M, Nägele M, Combé S, Reich J, Studts J, et al. The impact of endotoxin masking on the removal of endotoxin during manufacturing of a biopharmaceutical drug product. J Chromatogr A. 2022;1671:462995. https://doi.org/10.1016/j.chroma.2022.462995

32. Solano G, Ainsworth S, Sánchez A, Villalta M, Sánchez P, Durán G, et al. Analysis of commercially available snake antivenoms reveals high contents of endotoxins in some products. Toxicon X. 2024;21:100187. https://doi.org/10.1016/j.toxcx.2024.100187

33. Zurbano BN, Tavarone E, Viacava BG, Dokmetjian JC, Cascone O, Fingermann M. Critical aspects on traditional antivenom production processes and their optimization by factorial analysis. Biologicals. 2020;68:65-73. https://doi.org/10.1016/j.biologicals.2020.08.005

34. Sánchez A, Cerdas M, Gutiérrez J, Vargas M, Segura Á, Herrera M, et al. Pilot-scale evaluation of a dynamic body-feed filtration system for primary clarification of snake antivenoms produced by the caprylic acid method. Toxicon X. 2024;23:100202. https://doi.org/10.1016/j.toxcx.2024.100202

35. Patra A, Kalita B, Mukherjee AK. Assessment of Quality, Safety, and Pre-Clinical Toxicity of an Equine Polyvalent Anti-Snake Venom (Pan Africa): Determination of Immunological Cross-Reactivity of Antivenom Against Venom Samples of Elapidae and Viperidae snakes of Africa. Netherlands: Elsevier Ltd.; 2018.

36. Neves-Ferreira AG, Perales J, Fox JW, Shannon JD, Makino DL, Garratt RC, et al. Structural and functional analyses of DM43, a snake venom metalloproteinase inhibitor from Didelphis marsupialis serum. J Biol Chem. 2002;277:13129-37. https://doi.org/10.1074/jbc.M200589200

37. Jurgilas PB, Neves-Ferreira AG, Domont GB, Perales J.PO41, a snake venom metalloproteinase inhibitor isolated from Philander opossum serum. Toxicon. 2003;42:621-8. https://doi.org/10.1016/j.toxicon.2003.08.006

38. Quirós S, Alape-Girón A, Angulo Y, Lomonte B. Isolation, characterization and molecular cloning of AnMIP, a new α-type phospholipase A2 myotoxin inhibitor from the plasma of the snake Atropoides nummifer (Viperidae: Crotalinae). Comp Biochem Physiol B Biochem Mol Biol. 2007;146:60-8. https://doi.org/10.1016/j.cbpb.2006.09.003

39. Shirai R, Toriba M, Hayashi K, Ikeda K, Inoue S. Identification and characterization of phospholipase A2 inhibitors from the serum of the Japanese rat snake, Elaphe climacophora. Toxicon. 2009;53:685-92. https://doi.org/10.1016/j.toxicon.2009.02.001

40. Scir A, Tanfani F, Bertoli E, Furlani E, Nadozie HO, Cerutti H, et al. The belonging of gpMuc, a glycoprotein from Mucuna pruriens seeds, to the Kunitz-type trypsin inhibitor family explains its direct anti-snake venom activity. Phytomedicine. 2011;18:887-95. https://doi.org/10.1016/j.phymed.2011.02.004

41. Shi Y, Ji MK, Xu JW, Lin X, Lin JY. High-level expression, purification, characterization and structural prediction of a snake venom metalloproteinase inhibitor in Pichia pastoris. Protein J.2012;31:212-21. https://doi.org/10.1007/s10930-012-9392-y

42. Santos-Filho NA, Sousa TS, Boldrini-França J, Santos-Silva LK, Menaldo DL, Henrique-Silva F, et al. rBaltMIP, a recombinant alpha-type myotoxin inhibitor from Bothrops alternatus (Rhinocerophis alternatus) snake, as a potential candidate to complement the antivenom therapy. Toxicon. 2016;124:53-62. https://doi.org/10.1016/j.toxicon.2016.10.018

43. Karain BD, Lee MK, Hayes WK. C₆₀ fullerenes as a novel treatment for poisoning and envenomation: A proof-of-concept study for snakebite. J Nanosci Nanotechnol. 2016;16:7764-71. https://doi.org/10.1166/jnn.2016.12851

44. Ferraz MC, De Oliveira JL, De Oliveira Junior JR, Cogo JC, Dos Santos MG, Franco LM, et al. The triterpenoid betulin protects against the neuromuscular effects of Bothrops jararacussu snake venom in vivo. Evid Based Complement Alternat Med. 2015;2015:939523. https://doi.org/10.1155/2015/939523

45. Bryan-Quirós W, Fernández J, Gutiérrez JM, Lewin MR, Lomonte B. Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2. Toxicon. 2019;157:1-7. https://doi.org/10.1016/j.toxicon.2018.11.292

46. Lewin M, Samuel S, Merkel J, Bickler P. Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation. Toxins (Basel). 2016;8:248. https://doi.org/10.3390/toxins8090248

47. Wang Y, Zhang J, Zhang D, Xiao H, Xiong S, Huang C. Exploration of the inhibitory potential of varespladib for snakebite envenomation. Molecules. 2018;23:391. https://doi.org/10.3390/molecules23020391

48. Lewin M, Gutiérrez J, Samuel SP, Herrera M, Bryan-Quirós W, Lomonte B, et al. Delayed oral LY333013 rescues mice from highly neurotoxic, lethal doses of Papuan Taipan (Oxyuranus scutellatus) Venom. Toxins (Basel). 2018;10:380. https://doi.org/10.3390/toxins10100380

49. Arias AS, Rucavado A, Gutiérrez JM. Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom. Toxicon. 2017;132:40-9. https://doi.org/10.1016/j.toxicon.2017.04.001

50. Lian Q, Zhong L, Fu K, Ji Y, Zhang X, Liu C, et al. Hepatic inhibitors expression profiling of venom-challenged Sinonatrix annularis and antidotal activities. Biomed Pharmacother. 2022;156:113900. https://doi.org/10.1016/j.biopha.2022.113900

51. Okot DF, Namukobe J, Vudriko P, Anywar G, Heydenreich M, Omowumi OA, et al. In vitro anti-venom potentials of aqueous extract and oils of Toona ciliata M. Roem against cobra venom and chemical constituents of oils. Molecules. 2023;28:3089. https://doi.org/10.3390/molecules28073089

52. Chen YJ, Tsai CY, Hu WP, Chang LS. DNA Aptamers against Taiwan banded Krait α-bungarotoxin recognize Taiwan cobra cardiotoxins. Toxins (Basel). 2016;8:66. https://doi.org/10.3390/toxins8030066

53. El-Aziz TM, Ravelet C, Molgo J, Fiore E, Pale S, Amar M, et al. Efficient functional neutralization of lethal peptide toxins in vivo by oligonucleotides. Sci Rep. 2017;7:7202. https://doi.org/10.1038/s41598-017-07554-5

54. Menzies SK, Clare RH, Xie C, Westhorpe A, Hall SR, Edge RJ, et al. In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus. Toxicon. 2022;14:100118. https://doi.org/10.1016/j.toxcx.2022.100118

55. Chandra V, Jasti J, Kaur P, Srinivasan A, Betzel CH, Singh TP. Structural basis of phospholipase A2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 Å crystal structure. Biochemistry. 2002;41:10914-19. https://doi.org/10.1021/bi0258593

56. González Rodríguez II, Francisco AF, Moreira-Dill LS, Quintero A, Guimarães CL, Fernandes CA, et al. Isolation and structural characterization of bioactive compound from Aristolochia sprucei aqueous extract with anti-myotoxic activity. Toxicon X. 2020;7:100049. https://doi.org/10.1016/j.toxcx.2020.100049

57. Ascoët S, De Waard M. Diagnostic and therapeutic value of aptamers in envenomation cases. Int J Mol Sci. 2020;21:3565. https://doi.org/10.3390/ijms21103565

58. Alomran N, Chinnappan R, Alsolaiss J, Casewell NR, Zourob M. Exploring the utility of ssDNA aptamers directed against snake venom toxins as new therapeutics for snakebite envenoming. Toxins (Basel). 2022;14:469. https://doi.org/10.3390/toxins14070469

59. Liu CC, Hsiao YC, Lai WJ, Chiou CC, Chu LJ, Lin YT, et al. Development and optimization of a DNA aptamer to delay β-bungarotoxin-induced lethality in a rodent model. Int J Biol Macromol. 2024;270:132240. https://doi.org/10.1016/j.ijbiomac.2024.132240

60. Ponnappan N, Budagavi DP, Chugh A. CyLoP-1: Membrane-active peptide with cell-penetrating and antimicrobial properties. Biochim Biophys Acta Biomembr. 2017;1859:167-76. https://doi.org/10.1016/j.bbamem.2016.11.002

61. Rodrigues M, De La Torre BG, Rádis-Baptista G, Santos NC, Andreu D. Efficient cellular delivery of β-galactosidase mediated by NrTPs, a new family of cell-penetrating peptides. Bioconjug Chem. 2011;22:2339-44. https://doi.org/10.1021/bc200421z

62. Rodrigues M, Santos A, De La Torre BG, Rádis-Baptista G, Andreu D, Santos NC. Molecular characterization of the interaction of crotamine-derived nucleolar targeting peptides with lipid membranes. Biochim Biophys Acta Biomembr. 2012;1818:2707-17. https://doi.org/10.1016/j.bbamem.2012.06.014

63. Sieber M, Bosch B, Hanke W, De Lima VM. Membrane-modifying properties of crotamine, a small peptide-toxin from Crotalus durissus terifficus venom. Biochim Biophys Acta. 2014;1840:945-50. https://doi.org/10.1016/j.bbagen.2013.10.031

64. Falcao CB, Radis-Baptista G. Crotamine and crotalicidin, membrane active peptides from Crotalus durissus terrificus rattlesnake venom, and their structurally-minimized fragments for applications in medicine and biotechnology. Peptides (NY). 2020;126:170234. https://doi.org/10.1016/j.peptides.2019.170234

65. Pérez-Peinado C, Dias SA, Domingues MM, Benfield AH, Freire JM, Rádis-Baptista G, et al. Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15-34), antimicrobial peptides from rattlesnake venom. J Biol Chem. 2018;293:1536-49. https://doi.org/10.1074/jbc.RA117.000125

66. Pérez-Peinado C, Defaus S, Andreu D. Hitchhiking with nature: Snake venom peptides to fight cancer and superbugs. Toxins (Basel). 2020 ;12(4):255. https://doi.org/10.3390/toxins12040255.

67. Titus JK, Kay MK, Glaser JJ, Hwang YY. Application of phage display for the development of a novel inhibitor of PLA2 activity in western cottonmouth venom. Toxicon. 2019;158:S35. https://doi.org/10.1016/j.toxicon.2018.10.124

68. El-Aziz TM, Soares AG, Stockand JD. Snake venoms in drug discovery: Valuable therapeutic tools for life saving. Toxins (Basel). 2019;11:564. https://doi.org/10.3390/toxins11100564

69. Lynagh T, Kiontke S, Meyhoff-Madsen M, Gless BH, Johannesen J, Kattelmann S, et al. Peptide inhibitors of the α-cobratoxin-nicotinic acetylcholine receptor interaction. J Med Chem. 2020;63:13709-18. https://doi.org/10.1021/acs.jmedchem.0c01202

70. Liu BS, Wu WG, Lin MH, Li CH, Jiang BR, Wu SC, et al. Identification of immunoreactive peptides of toxins to simultaneously assess the neutralization potency of antivenoms against neurotoxicity and cytotoxicity of Naja atra venom. Toxins (Basel). 2018;10:10. https://doi.org/10.3390/toxins10010010

71. Camperi SA, Acosta G, Barredo GR, Iglesias-García LC, Alves Da Silva Caldeira C, Martínez-Ceron MC, et al. Synthetic peptides to produce antivenoms against the Cys-rich toxins of arachnids. Toxicon X. 2020;6:100038. https://doi.org/10.1016/j.toxcx.2020.100038

72. Rodríguez JA, Barredo-Vacchelli GR, Iglesias-García LC, Birocco AM, Blachman A, Acosta G, et al. Design and synthesis of peptides from Phoneutria nigriventer δ-ctenitoxin-Pn2a for antivenom production. Int J Pept Res Ther. 2023;29:1-11. https://doi.org/10.1007/s10989-023-10491-9

73. Saladini LY, Magalhães-Junior MJ, Da Silva CC, Oliveira PG, Kodama RT, Gomes L, et al. Evaluation of the inhibitory potential of synthetic peptides homologous to CDR3 regions of a monoclonal antibody against bothropic venom serine proteases. Int J Mol Sci. 2024;25:5181. https://doi.org/10.3390/ijms25105181

74. Chanda A, Salvi NC, Shelke PV, Kalita B, Patra A, Puzari U, et al. Supplementation of polyclonal antibodies, developed against epitope-string toxin-specific peptide immunogens, to commercial polyvalent antivenom, shows improved neutralization of Indian Big Four and Naja kaouthia snake venoms. Toxicon X. 2024;24:100210. https://doi.org/10.1016/j.toxcx.2024.100210

75. Fang RH, Luk BT, Hu CM, Zhang L. Engineered nanoparticles mimicking cell membranes for toxin neutralization. Adv Drug Deliv Rev. 2015;90:69-80. https://doi.org/10.1016/j.addr.2015.04.001

76. Waghmare AB, Salvi NC, Deopurkar RL, Shenoy PA, Sonpetkar JM. Evaluation of health status of horses immunized with snake venom and montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) during polyvalent snake antivenom production: Hematological and biochemical assessment. Toxicon. 2014;82:83-92. https://doi.org/10.1016/j.toxicon.2014.02.012

77. Weisman A, Chou B, O’Brien J, Shea KJ.Polymer antidotes for toxin sequestration. Adv Drug Deliv Rev. 2015;90:81-100. https://doi.org/10.1016/j.addr.2015.05.011

78. O’Brien J, Lee SH, Onogi S, Shea KJ.Engineering the protein corona of a synthetic polymer nanoparticle for broad-spectrum sequestration and neutralization of venomous biomacromolecules. J Am Chem Soc. 2016;138:16604-7. https://doi.org/10.1021/jacs.6b10950

79. Gláucia-Silva F, Torres-Rêgo M, Rocha Soares KS, Damasceno IZ, Tambourgi DV, Silva-Júnior AA, et al. A biotechnological approach to immunotherapy: Antivenom against Crotalus durissus cascavella snake venom produced from biodegradable nanoparticles. Int J Biol Macromol. 2018;120:1917-24. https://doi.org/10.1016/j.ijbiomac.2018.09.203

80. Rodríguez K, Villalta M, Marín E, Briceño M, León G, Montero ML. Physical characteristics of nano-hydroxyapatite pickering-emulsions and their adjuvant activity on the antibody response towards the Bothros asper snake venom. Mater Sci Eng. 2019;100:23-9. https://doi.org/10.1016/j.msec.2019.02.088

81. Soares KS, Gláucia-Silva F, Daniele-Silva A, Torres-Rêgo M, Araújo NK, Menezes YA, et al. Antivenom production against Bothrops jararaca and Bothrops erythromelas snake venoms using cross-linked chitosan nanoparticles as an immunoadjuvant. Toxins (Basel). 2018;10:158. https://doi.org/10.3390/toxins10040158

82. Xie C, Slagboom J, Albulescu LO, Bruyneel B, Still KB, Vonk FJ, et al. Antivenom neutralization of coagulopathic snake venom toxins assessed by bioactivity profiling using nanofractionation analytics. Toxins (Basel). 2020;12:53. https://doi.org/10.3390/toxins12010053

83. Singh P, Yasir M, Khare R, Shrivastava R. Green synthesis of silver nanoparticles using Indian male fern (Dryopteris Cochleata), operational parameters, characterization and bioactivity on Naja naja venom neutralization. Toxicol Res (Camb). 2020;9:706-13. https://doi.org/10.1093/TOXRES/TFAA070

84. Ghosh R, Sarkhel S, Saha K, Parua P, Chatterjee U, Mana K, et al. Synthesis, characterization & evaluation of venom neutralization potential of silver nanoparticles mediated Alstonia scholaris Linn bark extract. Toxicol Rep. 2021;8:888-95. https://doi.org/10.1016/j.toxrep.2021.04.006

85. Proença-Assunção JD, Farias-De-França AP, Tribuiani N, Cogo JC, Collaço RC, Randazzo-Moura P, et al. The influence of silver nanoparticles against toxic effects of Philodryas olfersii venom. Int J Nanomed. 2021;16:3555-64. https://doi.org/10.2147/IJN.S293366

86. Santos-Silva ED, Dos, Torres-Rêgo M, Gláucia-Silva F, Feitosa RC, Lacerda AF, Rocha HA, et al. Cationic PLGA nanoparticle formulations as biocompatible immunoadjuvant for serum production and immune response against Bothrops jararaca venom. Toxins (Basel). 2022;14:888. https://doi.org/10.3390/toxins14120888

87. Parua P, Saha K, Sarkhel S, Chatterjee U, Jamal NA, Pradhan SM. Synthesis of silver nanoparticles using Quillaja saponaria Molina bark extract and its antivenom activities. Indian J Exp Biol. 2023;61:753-60. https://doi.org/10.56042/ijeb.v61i10.1653

88. Sánchez A, Segura Á, Vargas M, Herrera M, Villalta M, Estrada R, et al. Expanding the neutralization scope of the EchiTAb-plus-ICP antivenom to include venoms of elapids from Southern Africa. Toxicon. 2017;125:59-64. https://doi.org/10.1016/J.TOXICON.2016.11.259

89. Ramos-Cerrillo B, De Roodt AR, Chippaux JP, Olguín L, Casasola A, Guzmán G, et al. Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers and elapids. Toxicon. 2008;52:881-8. https://doi.org/10.1016/J.TOXICON.2008.09.002

90. Herrera M, Paiva OK, Pagotto AH, Segura A, Serrano SM, Vargas M, et al. Antivenomic characterization of two antivenoms against the venom of the Taipan, Oxyuranus scutellatus, from papua new guinea and Australia. Am J Trop Med Hyg. 2014;91:887-94. https://doi.org/10.4269/AJTMH.14-0333

91. Muniz EG, Sano-Martins IS, Saraiva MD, Magno ES, Oliveira SS. Ability of brazilian Bothrops-Lachesis-Crotalus antivenom in neutralizing some biological activities of Crotalus durissus ruruima rattlesnake venom. Toxicon. 2025;254:108211. https://doi.org/10.1016/J.TOXICON.2024.108211

92. Lajoye Q, Bouaoud M, Le Roux G, Weinmann L, Labadie M, Larréché S. Paraspecificity of Mexican antivipmyn TRI antivenom in envenomation by Chinese Protobothrops mangshanensis (Mangshan pit viper) in France: A case report and experimental neutralization of venom procoagulant effect. Toxicon. 2024;247:107826. https://doi.org/10.1016/J.TOXICON.2024.107826

93. Alfaro-Chinchilla A, Segura Á, Gómez A, Díaz C, Corrales G, Chacón D, et al. Expanding the neutralization scope of the Central American antivenom (PoliVal-ICP) to include the venom of Crotalus durissus pifanorum. J Proteomics. 2021;246:104315. https://doi.org/10.1016/J.JPROT.2021.104315

94. Antitoxins and Sera : SNAKE ANTIVENIN. Available from: https://www.vaccinehaffkine.com/products/antitoxins/sera/snake/antivenin/detail.html [Last accessed on 2025 Dec 16].

95. Premium Serums and Vaccines Pvt Ltd. Available from: https://www.premiumserums.com/products.html [Last accessed on 2025 Dec 16].

96. Serum Institute of India. Available from: https://www.seruminstitute.com/product_ind_antisnake.php [Last accessed on 2025 Dec 16].

97. Anti Venom - ViNS Bio. Available from: https://vinsbio.in/anti-venom [Last accessed 2025 Dec 16].

98. Patra A, Kalita B, Khadilkar MV, Salvi NC, Shelke PV, Mukherjee AK. Assessment of quality and pre-clinical efficacy of a newly developed polyvalent antivenom against the medically important snakes of Sri Lanka. Sci Rep. 2021;11:18238. https://doi.org/10.1038/s41598-021-97501-2

99. Queen Saovabha Memorial Institute - DCVMN. Available from: https://dcvmn.org/member/qsmi [Last accessed on 2025 Dec 16].

100. Antivipmyn - Drug Targets, Indications, Patents - Synapse. Available from: https://synapse.patsnap.com/drug/c96248bdb2b4407bb3b302f a0bca6626? [Last accessed on 2025 Dec16].

101. Solano G, Cunningham S, Edge RJ, Duran G, Sanchez A, Villalta M, et al. African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: Evidence for increasing antivenom shelf life to aid in alleviating chronic shortages. BMJ Glob Health. 2024;9:e014813. https://doi.org/10.1136/bmjgh-2023-014813

102. Tan CH, Liew JL, Tan KY, Tan NH. Assessing SABU (Serum Anti Bisa Ular), the sole Indonesian antivenom: A proteomic analysis and neutralization efficacy study. Sci Rep. 2016;6:37299. https://doi.org/10.1038/srep37299

103. Potet J, Singh S, Ritmeijer K, Sisay K, Alcoba G, Jouberton F, et al. Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues. Toxicon X. 2023;17:100146. https://doi.org/10.1016/j.toxcx.2022.100146

104. CroFab. Copperhead, Cottonmouth, and Rattlesnake Antivenom. Available from: https://crofab.com [Last accessed on 2025 Dec 17].

105. D Vaz De Melo P, De Almeida Lima S, Araújo P, Medina Santos R, Gonzalez E, Alves Belo A, et al. Immunoprotection against lethal effects of Crotalus durissus snake venom elicited by synthetic epitopes trapped in liposomes. Int J Biol Macromol. 2020;161:299-307. https://doi.org/10.1016/j.ijbiomac.2020.05.171

106. Hamzaoui A, Laraba-Djebari F. Development and evaluation of polymeric nanoparticles as a delivery system for snake envenoming prevention. Biologicals. 2021;70:44-52. https://doi.org/10.1016/j.biologicals.2021.01.003

107. Fox CB, Khandhar AP, Khuu L, Phan T, Kinsey R, Cordero D, et al. Physicochemical and immunological effects of adjuvant formulations with snake venom antigens for immunization of horses for antivenom production. Toxicon. 2023;232:107229. https://doi.org/10.1016/j.toxicon.2023.107229

108. Watson JL, Juergens D, Bennett NR, Trippe BL, Yim J, Eisenach HE, et al. De novo design of protein structure and function with RFdiffusion. Nature. 2023;620:1089-100. https://doi.org/10.1038/s41586-023-06415-8

109. Callaway E. AI-designed proteins tackle century-old problem - making snake antivenoms. Nature. 2025;637:776. https://doi.org/10.1038/d41586-025-00133-z

110. Wilcox C. AI-designed miniproteins neutralize snake toxins. Science. 2025;387:237. https://doi.org/10.1126/science.adv9835

111. Vázquez Torres S, Benard Valle M, Mackessy SP, Menzies SK, Casewell NR, Ahmadi S, et al. De novo designed proteins neutralize lethal snake venom toxins. Nature. 2025;639:225-31. https://doi.org/10.1038/s41586-024-08393-x

112. Bedraoui A, Suntravat M, El Mejjad S, Enezari S, Oukkache N, Galan JA, et al. Therapeutic potential of snake venom: Toxin distribution and opportunities in deep learning for novel drug discovery. Med Drug Discov. 2024;21:100175. https://doi.org/10.1016/J.MEDIDD.2023.100175

113. Brewer MS, Cole TJ.TOXIFY: A deep learning approach to classify animal venom proteins. PeerJ.2019;7:e7200. https://doi.org/10.7717/peerj.7200

114. Gutiérrez JM. Novel proteins to neutralize venom toxins. N Engl J Med. 2025;392:2065-8. https://doi.org/10.1056/NEJMCIBR2501084

115. Using AI to Design Proteins Against Deadly Snake Venom Future Medicine AI. Available from: https://www.fmai-hub.com/using-ai-to-design-proteins-against-deadly-snake-venom [Last accessed on 2025 Dec 17].

116. AI-designed Proteins Neutralise Snake Toxins. Available from: https://www.dtu.dk/english/newsarchive/2025/01/ai-designed-proteins-neutralise-snake-toxins [Last accessed on 2025 Dec 17].

117. AI-Designed Proteins Neutralize Toxins Found in Snake Venom. Available from: https://phys.org/news/2025-01-ai-proteins-neutralize-toxins-snake.html. [Last accessed on 2025 Dec 17].

118. Kalogeropoulos K, Rosca V, O’brien C, Christensen CR, Grahadi R, Sørensen CV, et al. V-ToCs (Venom Toxin Clustering): A tool for the investigation of sequence and structure similarities in snake venom toxins. Toxicon. 2024;250:108088. https://doi.org/10.1016/j.toxicon.2024.108088

Article Metrics

Related Search

By author names

Similar Articles